Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$5.78 - $7.33 $201,328 - $255,318
-34,832 Reduced 65.8%
18,106 $109,000
Q4 2023

Oct 21, 2024

BUY
$3.6 - $7.15 $190,576 - $378,506
52,938 New
52,938 $371,000
Q4 2023

Feb 07, 2024

BUY
$3.6 - $7.15 $190,576 - $378,506
52,938 New
52,938 $371,000
Q4 2022

Feb 13, 2023

BUY
$5.8 - $8.98 $170,850 - $264,523
29,457 New
29,457 $192,000
Q2 2022

Aug 09, 2022

BUY
$6.8 - $14.23 $680 - $1,423
100 Added 0.51%
19,900 $151,000
Q1 2022

May 12, 2022

SELL
$13.42 - $23.38 $79,178 - $137,942
-5,900 Reduced 22.96%
19,800 $274,000
Q4 2021

Feb 10, 2022

BUY
$12.78 - $23.74 $328,446 - $610,118
25,700 New
25,700 $610,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.